Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Receivables - Accured (2016 - 2017)

Tenax Therapeutics' Receivables - Accured history spans 4 years, with the latest figure at $71169.0 for Q3 2017.

  • For Q3 2017, Receivables - Accured fell 60.92% year-over-year to $71169.0; the TTM value through Sep 2017 reached $71169.0, down 60.92%, while the annual FY2016 figure was $108813.0, N/A changed from the prior year.
  • Receivables - Accured for Q3 2017 was $71169.0 at Tenax Therapeutics, down from $82994.0 in the prior quarter.
  • Across five years, Receivables - Accured topped out at $364080.0 in Q3 2015 and bottomed at $71169.0 in Q3 2017.
  • The 4-year median for Receivables - Accured is $248070.0 (2016), against an average of $224897.1.
  • The largest annual shift saw Receivables - Accured rose 28.48% in 2015 before it tumbled 63.95% in 2017.
  • A 4-year view of Receivables - Accured shows it stood at $313848.0 in 2014, then decreased by 5.37% to $297005.0 in 2015, then tumbled by 63.36% to $108813.0 in 2016, then plummeted by 34.6% to $71169.0 in 2017.
  • Per Business Quant, the three most recent readings for TENX's Receivables - Accured are $71169.0 (Q3 2017), $82994.0 (Q2 2017), and $89425.0 (Q1 2017).